{"id":18652,"date":"2020-11-04T13:59:36","date_gmt":"2020-11-04T12:59:36","guid":{"rendered":"https:\/\/ellipse.prbb.org\/?p=18652"},"modified":"2020-11-04T13:59:23","modified_gmt":"2020-11-04T12:59:23","slug":"identificats-els-tumors-benignes-de-mama-amb-major-risc-devolucio-cancerigena","status":"publish","type":"post","link":"https:\/\/ellipse.prbb.org\/ca\/identificats-els-tumors-benignes-de-mama-amb-major-risc-devolucio-cancerigena\/","title":{"rendered":"Identificats els tumors benignes de mama amb major risc d’evoluci\u00f3 cancer\u00edgena"},"content":{"rendered":"\n

Investigadors i investigadores de l‘Institut Hospital de la Mar de Recerques M\u00e8diques (IMIM)<\/a>\u00a0han revelat<\/a> en el 12\u00e8 Congr\u00e9s Europeu de C\u00e0ncer de Mama, quins tipus de tumors benignes de mama<\/strong> (BBD\u00a0per les seves sigles en angl\u00e8s,\u00a0Benign\u00a0Breast\u00a0Disease)\u00a0o \u00abprotuber\u00e0ncies no cancer\u00edgenes\u00bb comporten un major risc de posterior desenvolupament de c\u00e0ncer de mama<\/a><\/strong>.<\/p>\n\n\n\n

L’estudi, realitzat en col\u00b7laboraci\u00f3 amb l’Hospital del Mar ha analitzat les dades de 629.087 dones<\/strong>, que inclo\u00efen 2.327.384 mamografies<\/strong> realitzades entre 1995 i 2015 i amb seguiment fins al 2017.<\/strong><\/p>\n\n\n\n

Els resultats, recollits en la seg\u00fcent taula, mostren el risc augmentat del desenvolupament de c\u00e0ncer de mama<\/a> segons els diferents tipus<\/a> de\u00a0BBD\u00a0detectat respecte al risc sense pres\u00e8ncia de\u00a0BBD:<\/p>\n\n\n\n

<\/div>\n\n\n\n
<\/td><\/td>a. PREVALENTS<\/strong><\/td>b. INCIDENTS<\/strong><\/td><\/tr>
<\/td><\/td>x1,87<\/td>x2,67<\/td><\/tr>
1. NO PROLIFERATIU<\/strong><\/td>x1,96<\/td>x1,63<\/td>x2,39<\/td><\/tr>
2. PROLIFERATIU<\/strong><\/td>x3,28<\/td>x2,85<\/td>x4 (aprox)<\/td><\/tr><\/tbody><\/table>
a.\u00a0PREVALENT<\/em>: Tumor benigne detectat en la primera cita<\/strong> d’un programa de cribratge.
b. INCIDENT<\/em>: Tumor benigne detectat en les successives visites<\/strong> (cada dos anys).
1. NO PROLIFERATIU<\/em>: Sense creixement<\/strong> de determinades c\u00e8l\u00b7lules del teixit mamari
2. PROLIFERATIU<\/em>: Amb creixement<\/strong> de determinades c\u00e8l\u00b7lules del teixit mamari<\/figcaption><\/figure>\n\n\n\n
<\/div>\n\n\n\n

El major risc, per tant, es d\u00f3na en dones amb tumors benignes incidents proliferatius<\/strong>, que presenten \u00abgaireb\u00e9 quatre vegades m\u00e9s risc de desenvolupar c\u00e0ncer de mama que les dones sense BBD\u00bb<\/strong> segons la investigadora Marta Rom\u00e1n.<\/p>\n\n\n\n

<\/div>\n\n\n\n

\u201cIncloure informaci\u00f3 sobre les BBD, a m\u00e9s d’altres factors, per desenvolupar abordatges en el cribratge basats en el risc podria ajudar a predir si una dona podria desenvolupar un c\u00e0ncer de mama en un per\u00edode de temps determinat\u201d
Marta Rom\u00e1n<\/strong>, IMIM<\/p><\/blockquote>\n\n\n\n

<\/div>\n\n\n\n

Amb aquests resultats, comenten els autors, es podrien fer m\u00e8todes de cribratge m\u00e9s espec\u00edfics<\/strong> que es tradu\u00efssin en pron\u00f2stics i estrat\u00e8gies personalitzades<\/strong> per a cada pacient. En definitiva, l’estudi podria servir per a millorar la comprensi\u00f3 del risc associat a la BBD<\/strong> i augmentar la consideraci\u00f3 d’aquesta en les prediccions de risc de c\u00e0ncer de mama<\/strong> en el futur.<\/p>\n","protected":false},"excerpt":{"rendered":"

Un estudi de l’IMIM i l’Hospital del Mar ha revelat que els tumors benignes de mama incidents i proliferatius impliquen un major risc de desenvolupament de c\u00e0ncer.<\/p>\n","protected":false},"author":9,"featured_media":18581,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[312,497,213,521],"new-type":[35],"class_list":["post-18652","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recerca","tag-cancer-ca","tag-cancer-de-mama","tag-imim","tag-salut","new-type-noticies"],"acf":[],"_links":{"self":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/18652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/comments?post=18652"}],"version-history":[{"count":6,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/18652\/revisions"}],"predecessor-version":[{"id":18685,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/posts\/18652\/revisions\/18685"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media\/18581"}],"wp:attachment":[{"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/media?parent=18652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/categories?post=18652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/tags?post=18652"},{"taxonomy":"new-type","embeddable":true,"href":"https:\/\/ellipse.prbb.org\/ca\/wp-json\/wp\/v2\/new-type?post=18652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}